PHARMA CALL SL
Company details
- Active NIF/CIF: B66164872
-
-
-
-
Address: Avinguda Eduard Maristany, 430, 08918 Badalona, Barcelona, España See in map
-
-
Featured products:
More information on PHARMA CALL SL
-
MICHELE MARINOConsejeroAppointment: 04/03/2014Termination of employment: 01/02/2017
-
MICHELE MARINOConsejero delegadoAppointment: 04/03/2014Termination of employment: 01/02/2017
-
VILLARROYA PEREZ JAVIERConsejeroAppointment: 04/03/2014
-
VILLARROYA PEREZ JAVIERConsejero delegadoAppointment: 04/03/2014
-
ROIG MOLINA NURIAConsejeroAppointment: 04/03/2014
-
ROIG MOLINA NURIAConsejero delegadoAppointment: 04/03/2014
-
ROIG MOLINA NURIASecretarioAppointment: 04/03/2014
-
GIANPIERO DE MESTRIAConsejeroAppointment: 04/03/2014
-
GIANPIERO DE MESTRIAPresidenteAppointment: 04/03/2014
Other information
The CIF assigned to PHARMA CALL SL is B66164872, and its current commercial status is active. The company is engaged in economic activities within the CNAE 4774 - Comercio al por menor de artículos médicos y ortopédicos en establecimientos especializados. As for its SIC classification, it is 5999 - Detallistas diversos.
The company PHARMA CALL SL has a team of Between 10 and 49 employees and reports annual revenues of less than 2 million euros. Registered in the Mercantile Registry of Barcelona, it has a total of 9 registered positions. Its most recent announcement in the Borme was published on 01/02/2017, and the last deposit of its annual accounts corresponds to the year 2021.
To find out more contact details of PHARMA CALL SL, such as telephone number, address, or website, you can consult the Company Data module.
If you want to obtain more information about PHARMA CALL SL, you can review one of the available financial reports, the company's Annual Accounts, or check for any default incidents in the RAI delinquency file.
The financial, commercial, and legal information of PHARMA CALL SL comes from official sources and is constantly updated.
Do you want to know more about PHARMA CALL SL??
Find out more about this company by consulting these reports: